Shares at Radius Jump as Bone Drug of Amgen Has Setback
Late Sunday Amgen revealed that safety problems emerged in its clinical testing for an osteoporosis drug known as romosozumba (Evenity). The development will at a minimum delay the path of the drug to...
Aerospace & Defense
Flight Attendants Accuse Frontier Airlines of Not Allowing Breast Feeding
More »
- Spirit Airlines Cancellations Cause Chaos in Airport
- China’s C919 Completes Maiden Flight
- United Earnings Meet Expectations, But Fall 52%
- Air France to Launch No-Frills Airline For U.S. and Asia
- Delta’s Profit for Second Quarter Rises But Revenue Falls
- Boeing Announces Historic Deal with Iran Air
- JetBlue Planning Mint Service Expansion After Losing Virgin America Bid
- Southwest Wants to Fly Out of Long Beach
Banking
Citigroup Inc Analysts Give ING Groep NV (INGA) a €17.35 Price Target
More »
- OVERSEA-CHINESE BK (OVCHY) Lowered to Sell at Zacks Investment Research
- Old Republic International Co. (ORI) Rating Increased to Buy at Zacks Investment Research
- Infineon Technologies AG (IFXA) Stock Rating Reaffirmed by Deutsche Bank AG
- Berenberg Bank Analysts Give HeidelbergCement AG (HEI) a €99.00 Price Target
- Oppenheimer Holdings Inc. Reaffirms “Outperform” Rating for United Parcel Service, Inc. (UPS)
- Zacks Investment Research Lowers Team, Inc. (TISI) to Strong Sell
- Time Warner’s (TWX) Hold Rating Reiterated at BMO Capital Markets
- TheStreet Lowers Abbott Laboratories (ABT) to C+
Pharmaceuticals
Shares at Radius Jump as Bone Drug of Amgen Has Setback
More »
- FDA Approves New Treatment for ALS
- Valeant Pharmaceuticals Cuts Debt Following L’Oreal Deal
- FDA Gives Approval to New Powerful Eczema Drug
- Trump Tweet Sends Pharmaceutical Stocks Tumbling
- Shares of Kite Pharma Flying High After Reaching Study Goal
- Pharmaceuticals Shunning Push by Trump for FDA Shift
- Cigna Changes to Generic EpiPen, CVS Cuts Prices
- Pfizer and OPKO Drug for Growth Hormone Deficiency Fails Study
Goods & Commodities
Hyundai and Kia Recall Ordered by South Korea Officials
More »
- Mattel CEO Promises Growth Following Sales Slump
- Burberry Misses Estimates on Sales
- Tesla Deliveries Set Record for One Quarter at 25,000
- FedEx Comes Up Short on Earnings
- Brazil Looks to Calm Fears Over Export and Sale of Meat
- Dollar General Increasing Pay, Lowering Price and Adding Perishable Goods
- Shares of Staples Fall After Earnings Come Up Short
- Opel Sold by General Motors to PSA
Technology
Blackberry Returns as Stock Surges Following WannaCry
More »
- General Motors’ Maven Launches in New York City
- Apple iPhone Sales Drop, Shares Follow Suit
- Revenue at Twitter Beats the Street, Monthly Users Increase
- McDonald’s Ordering Via Mobile Could Give Handsome Return
- Snapchat: CEO Did Not Label India as Being Poor
- Executive With Uber Invokes Fifth Amendment
- Euronet Worldwide Tops Offer by Ant to Acquire MoneyGram
- Snapchat Could Be Given Difficult Test by Asia Rival
Energy & Mining
Fuel Shortage in Venezuela Growing Worse
More »
- Oil Prices Drop to Low of Three Months on Rig Count
- The 2016 oil market: a year in review
- What’s next for the oil market as it reaches a critical point?
- Exxon Issues Warning on Reserves After Posting Drop in Profit
- Shell Posts Disappointing Results As Profit Hit by BG Deal and Oil
- DONG Energy Stock Surges After Largest European IPO in 2016
- SunEdison Said to be Preparing to File Bankruptcy
- West Virginia Gives Tax Break to Natural Gas and Coal
Free Email Newsletter
Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:
Follow Ticker Report
Recent Posts
- Berenberg Bank Analysts Give HeidelbergCement AG (HEI) a €99.00 Price Target
- Infineon Technologies AG (IFXA) Stock Rating Reaffirmed by Deutsche Bank AG
- Old Republic International Co. (ORI) Rating Increased to Buy at Zacks Investment Research
- OVERSEA-CHINESE BK (OVCHY) Lowered to Sell at Zacks Investment Research
- Citigroup Inc Analysts Give ING Groep NV (INGA) a €17.35 Price Target
- Oppenheimer Holdings Inc. Reaffirms “Outperform” Rating for United Parcel Service, Inc. (UPS)
- Time Warner’s (TWX) Hold Rating Reiterated at BMO Capital Markets
- Zacks Investment Research Lowers Team, Inc. (TISI) to Strong Sell
- TheStreet Lowers Abbott Laboratories (ABT) to C+
- Zacks Investment Research Lowers Apache Co. (APA) to Sell
- Avery Dennison Corp (AVY) Stock Rating Upgraded by Zacks Investment Research
- AMETEK, Inc. (AME) Downgraded by Zacks Investment Research
- Cheetah Mobile Inc (CMCM) Trading -5.1% Higher After Earnings Beat
- Booz Allen Hamilton Holding Co. (BAH) Shares Gap Up on Better-Than-Expected Earnings
- Radius Health Inc (RDUS) Shares Gap Up After Insider Buying Activity
- Wells Fargo & Co Reaffirms “Sell” Rating for Valeant Pharmaceuticals Intl Inc (VRX)
- Vetr Inc. Downgrades Valeant Pharmaceuticals Intl Inc (VRX) to Buy
- Veritiv Corp (VRTV) Upgraded to Outperform by Wells Fargo & Co
- BMO Capital Markets Reiterates Hold Rating for Yum! Brands, Inc. (YUM)
- HC Wainwright Reiterates “Buy” Rating for Rexahn Pharmaceuticals, Inc. (RNN)
© 2006-2017 Ticker Report. Google+.